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In a  previous study reported from this laboratory (1), at least two common, 
qualitatively tumor-specific antigens  or  antigenic  determinants  were  demon- 
strated to be present in adenocarcinomata of the human colon. These antigenic 
components  were  unrelated  to  iso-antigens, bacterial contaminants,  or  fibrin 
deposits. The present investigation was undertaken  to determine whether  the 
antigens found  to be specific for colonic carcinomata could be detected  (a)  in 
other  adult  human  tissues,  or  (b)  in  human  embryonic  and  fetal  tissues  at 
various stages of gestation. 
Certain  investigators  have  suggested  the  existence  of  universal  tumor- 
specific antigens common to all forms of human malignant tumors  (2-4), while 
others have attempted to classify human cancers on the basis of the particular 
tumor-specific  antigens  that  they  may  contain  (5).  These  concepts  have, 
however,  been  challenged  (6)  and  their  general  acceptance  awaits  further 
experimental  study  (7). 
Materials and Methods 
Preparation of the Human Colonic Tumor Tissue Extract  (T1)--The pooled colonic  tu- 
mor tissue extract was prepared according to the method previously described (1). 
Preparation of the Anticolonic Tumor-Specific Antiserum (tl-abs).--Rabbits were immunized 
with the extract of pooled colonic carcinomata (T1), and the anti-tumor antiserum thus pro- 
duced was absorbed with a  pooled extract of normal human colon and with human blood 
components.  The procedure followed was identical to that previously described  (1). 
Extraction Procedure for the Individual Human Tissue Specimens.--Tissue  specimens to be 
tested were obtained either at operation or at autopsy within 12 hours of death. Tissue diag- 
noses were determined by histological examination. A portion of each specimen was extracted 
by the procedure used for the preparation of T1 except that the supernatants obtained fol- 
lowing  the  centrifugation steps were  lyophylized. Immediately before  initial testing, the 
powdered material was dissolved in the smallest volume of distilled water which would allow 
complete resolution.  The protein concentrations of these solutions  varied from  80  to  100 
mg/ml  (Kjeldahl). 
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Precipitin-Inhibition and  Direct Ouchterlony  Reactions.--Both  types of reactions were per- 
formed in agar gel plates prepared as previously described (1). The patterns were cut in the 
gel plates so that the central well was spaced 1 cm from each of the six peripheral wells. 
In the precipitin-inhibition reactions,  the central well was filled with 0.15 ml of T~ (10 mg 
protein/ml). A volume of 0.075  ml of tl-abs was placed into each of the six peripheral wells. 
Interaction of T1 with tl-abs was known to give rise to a reproducible pattern consisting of a 
single tumor-specific precipitin band (1). 
To one of the six peripheral well,  0.075 mt of saline was added so that the usual precipitin 
band could develop. To a second peripheral well,  0.075 ml of T1 was added so that complete 
inhibition of the precipitin band was achieved.  To  each of the other four peripheral wells, 
0.075 ml of an extract  of an individual tissue specimen was added.  If the usual single band 
failed to develop between the central  well and one of the peripheral wells, it was considered 
that  the  tumor-specific  antigen(s)  of  T1  and  the  test  antigenic  material  shared  common 
antigenic determinant groups.  Failure of the expected precipitin band  to  appear constituted 
a positive precipitin-inhibition reaction. 
The initial protein  concentration of the test antigenic materials placed in the peripheral 
wells was 80 to  100 mg/ml. If a  positive precipitin-inhibition test was obtained, the active 
test material was serially diluted and the precipitin-inhibition reactions were repeated until a 
negative test was obtained. It was therefore possible to determine the degree to which an ex- 
tract could be diluted but still retain demonstrable antigenic (i.e.,  inhibitory) activity. An 
active tissue extract, in the highest or next to highest dilution capable of producing precipitin- 
inhibition, was then used in a  direct Ouchterlony reaction against tl-abs. The use of diluted 
test extracts in the direct Ouchterlony reactions did much to overcome the problem of non- 
specific  precipitation  around  the  antigen  wells  which frequently  occurs with  concentrated 
tissue protein solutions. In many cases this phenomenon would have made interpretation of 
results difficult. 
RESULTS 
Extracts  of  322  human  tissue  specimens  were  studied  for  their  capacity  to 
inhibit the single tumor-specific precipitin band  formed  between  T1  and  tl-abs 
in  agar  gel.  Typical  precipitin-inhibition reactions  are  shown  in  Figs.  1  to  3, 
Fla.  i. Example  of  precipitin-inhibition  reactions,  all  test  extracts  negative.  Center, 
T1,  (A) tl-abs +  saline, (B) tl-abs +  T1,  (C)  tl-abs +  normal gastric mucosa, (D)  tl-abs + 
renal cell carcinoma, (E)tl-abs +  female breast carcinoma, (F) h-abs +  full-term placenta. PHIL  GOLD  AND  SAMUEL  O.  FREEDMAN  469 
and  the  results  of  the  precipitin-inhibition  experiments  are  summarized  in 
Tables I  and II. 
Precipitin-inhibition  was achieved with all of 40 tested specimens of primary 
carcinomata of adult digestive system organs (esophagus, stomach, duodenum, 
FIG. 2.  Example of precipitin-inhibition  reactions, high concentrations  of active extracts. 
Center, T1, (A) tl-abs  q- saline, (B) h-abs -}- T1, (C) tl-abs  ~  bronchogenic carcinoma, (D) 
tl-abs  -[- carcinoma of the rectum,  (E) tl-abs  q- gall bladder  (cholecystitis),  (F)  tx-abs q- 
carcinoma  of the stomach.  Test extracts  in D and F  were capable  of precipitin-inhibition. 
Bands formed between peripheral wells due to excess tumor-specific antigens in wells D and 
F and uninhibited  tumor-specific antibodies in wells A, C, and E. 
Fro. 3.  Example  of  precipitin-inhibition  reactions,  highest  dilution  of  active  extracts 
giving positive precipitin-inhibition  test.  Center, T1,  (A) trabs +  saline,  (B) tl-abs  +  T1, 
(C) tl-abs  +  carcinoma of the thyroid gland, (D) tl-abs  +  carcinoma of anterior  portion of 
floor of the mouth,  (E) tl-ab  +  carcinoma of the duodenum,  (F) tl-abs +  carcinoma of the 
colon. Test extracts in E  and  (F) were capable of precipitin-inhibition.  No bands formed be- 
tween peripheral wells, indicating lack of tumor-specific antigen excess in wells E and F. 
pancreas,  colon, and rectum).  Precipitin-inhibition  was also achieved with  all 
of the tested metastatic lesions from primary carcinomata of the gastrointesti- 
nal  tract  to  other  organs  (metastases  from  carcinomata  of  the  stomach  and 
colon to the lung and liver).  Direct Ouchterlony reactions between  h-abs and 
the  extracts  of  these  specimens,  in  the  highest  or  next  to  highest  dilutions 
producing precipitin-inhibition,  yielded  single  bands  in  all  cases.  Each of the 470  SPECIFIC CARCINOEMBRYONIC ANTIGENS 
bands  thus  formed  showed  a  reaction  of  complete  identity with  the  single 
tumor-specific precipitin band between '1"1 and h-abs (Fig. 4). The comparative 
effect  of dilution on the  inhibitory capacity of  the digestive tract  cancer ex- 
tracts  (Table I) would suggest that carcinomata of the lower bowel contained 
higher concentrations of inhibiting antigenic material than those of the upper 
digestive system organs. 
TABLE  I 
Tissue Specimens  Giving Positive Precipitin-lnhibition Reactions (Inhibition 
of Precipitin Band Formation  Between T1 and tx-abs) 
Group 
Group 1  : 
Primary carcino- 
mata (obtained 
at operation) 
Group II: 
Metastatic lesions 
(obtained at 
autopsy) from/ 
to 
Group III: 
Fetal tissues be- 
tween 2 and 6 
months of 
gestation 
Organ 
Esophagus 
Stomach 
Duodenum 
Pancreas 
Colon 
Rectum 
Colon/liver 
Colon/lung 
Stomach/liver 
Stomach/lung 
Gut 
Liver 
Pancreas 
* Number of specamens 
tration indicated. 
Protein concentration  of inhibiting  extract-mg/ml 
No. of 
speci- --  Pos  mens 180-100 I 40-50 I 20-25 110-12.5  5-6.  2.5-3.1 
tested  Posi- ] Posi-  Posi-  Posi- [ tive 
tire*  five*  five*  ] tive* 
I  I 
1  1  0 
8  8  4 
1  1  1 
2  2  2 
20  20  20 
8  8  8 
2  2 
2  2 
2  2 
2  2 
7  7 
7  7 
7  7 
! 
F 
2 
1 
1 
20 
8 
2  2 
2  2 
2  1 
2  1 
0  -- 
1  0 
1  0 
i 
0  --- 
0  -- 
0  -- 
19  8 
7  3 
2  1 
2  1 
0  -- 
0 
Posi- 
tive* 
0 
0 
0 
0 
giving positive precipitin-inhibition  reaction at protein  concen- 
All adult tissue specimens (normal or diseased, cancerous or non-cancerous), 
other  than those noted above, yielded negative results. It is particularly em- 
phasized  that  tumors of  stomatodaeal ectodermal origin (carcinomata of  the 
anterior portion of the floor of the mouth, of the hard palate, and a malignant 
mixed tumor of  the parotid gland)  were incapable of  inhibition. Similarly, a 
benign insulinoma of  the  pancreas,  benign polyps  of  the  colon and  rectum, 
and specimens of ulcerative colitis and colonic diverticulitis yielded negative 
results. Furthermore, metastatic tumor masses from other organs (ovary and 
prostate)  to  the  digestive system  (liver, pancreas,  and colon) were  devoid of 
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Similar  precipitin-inhibition  experiments  were  performed  with  extracts  of 
human  embryonic  and  fetal  tissues  between  2  and  8  months  of  gestation. 
These specimens were obtained following spontaneous abortion or death after 
premature delivery. All tested extracts of fetal gut, liver, and pancreas between 
2 and 6 months of gestation were capable of inhibiting the single tumor-specific 
precipitin band formed between T1 and h-abs  (Table I). Direct Ouchterlony 
reactions between these extracts and tl-abs produced single precipitin bands 
which showed reactions of complete identity with the tumor-specific precipitin 
band between T1 and h-abs (Fig. 4, well F). The concentrations of the active 
antigenic  constituents in  the  fetal digestive  tissues  as  determined  by serial 
dilution experiments were relatively low (Table I).  Fetal gut, liver, and pan- 
creas in the third trimester and all other tested fetal tissues at any time during 
gestation were devoid of precipitin-inhibiting capacity. 
DISCUSSION 
Specific  Cancer Antigens  of the Adult Human Digestive  System.--The  results 
of the  experiments with  adult human tissues revealed  that only primary or 
metastatic carcinomata originating in other digestive system organs  (esoph- 
agus,  stomach,  duodenom,  pancreas,  and  rectum)  contained  components 
identical with the colonic tumor-specific antigens. Metastatic lesions from car- 
cinomata of the ovary or prostate to the colon, pancreas, or liver showed no 
cross-reactivity with the colonic tumor-specific constituents. Therefore, it may 
be  concluded  that  the  tumor-specific  antigens detected in  digestive system 
cancers are a manifestation of factors determined by the site of origin, rather 
than the site of growth of the tumors. Furthermore, these findings exclude the 
possibility that the tumor-specific antigens are products of an interaction be- 
tween  a  growing,  invasive  mass  and  surrounding  normal  digestive  system 
tissue, or that they are related to exogenous contamination by enteric viruses. 
It was found that benign tumors of the pancreas, colon, and rectum lacked 
detectable tumor-specific antigens. These antigens would thus appear to have 
been produced only when the tumor cells had  attained some degree of ana- 
plasia; i.e.,  loss  of organization  (orientation)  and  differentiation (specializa- 
tion) (8). It was also observed that carcinomata of the lower bowel (colon and 
rectum)  contained higher concentrations of the tumor-specific antigens than 
cancers of the upper gastrointestinal tract (esophagus and stomach). 
The findings of Nairn et al.  (9,  10) are of considerable interest in relation to 
the present investigation. These workers reported that normal human gastro- 
intestinal  epithelium,  from  the  esophago-gastric  junction  to  the  recto-anal 
junction,  contained  a  specific  mucopolysaccharide  antigenic  material.  This 
material was present in greater quantities in the lower bowel epithelium than 
in the epithelium of the upper gastrointestinal tract (stomach) and tended to 
disappear  during  tumor  transformation in  relation  to  the  degree  of  tumor 
malignancy. Thus, benign colonic polyps still contained moderate amounts of TABLE  II 
Tissue Specimens Giving Negative Precipitin-Inhib#ion Reactions (No lnhib#ion 
of Precipitin Band Formation Between T1 and h-abe) 
Organ  No. of speci-  Pathological diagnosis  mens studied 
Digestive system: 
Floor of mouth* (anterior por- 
tion) 
Parotid gland* 
Submaxillary gland* 
Tongue~ 
Hard palate§ 
Esophagus§ 
Stomach* 
Stomach* 
Small bowel:~ 
Appendix* 
Gall bladder* 
Liver~; 
Liver:[ 
Liver~" 
Liver* 
Pancreas+  + 
Pancreas* 
Pancreas J; 
Pancreas:~ 
Colon* 
Colon* 
Colon* 
Colon* 
Colon* 
Colon* 
Colon++ 
Colon:~ 
Rectum~ 
Rectum* 
1 
12 
4 
2 
12 
4 
1 
1 
1 
4 
1 
1 
1 
12 
6 
3 
4 
4 
Primary carcinoma 
Mixed tumor (malignant) 
Mixed tumor (benign) 
Normal 
Primary carcinoma 
Epithelial  hyperplasia  with  submucosal 
edema 
Edge of benign ulcer 
Normal--partial  gastrectomies  for  duo- 
denal ulcers 
Normal 
Appendicitis 
Cholecystitis--choMithiasis 
Normal 
Metastases from carcinoma of the ovary 
Metastases from carcinoma of the prostate 
Cavernous hemangioma 
Normal 
Islet cell adenoma 
Metastases from carcinoma of the ovary 
Metastases from carcinoma of the prostate 
Normal--distal to carcinoma of the colon 
Normal 
Benign polyps 
Diverticulitis 
Ulcerative  colitis  with  pseudo-polyps 
(benign) 
Submucosal lipoma 
Metastases from carcinoma of the ovary 
Metastases from carcinoma of the prostate 
Normal 
Benign polyps 
Breast* 
Breast* 
Respiratory system: 
Nose* 
Lung~ 
Lung* 
Lung* 
Lung;~ 
Lung~ 
6 (5 female 
1 male) 
i 2 (female) 
Carcinoma 
Fibrocystic disease 
Nasal polyps 
Normal 
Bronchial adenoma 
Bronchogenic c~rcinoma 
Metastases from carcinoma of the prostate 
Metastases from carcinoma of the ovary 
Note:  With regard  to  fetal tissues,  the  term  "normal" appearing in  the  "Pathological 
Diagnosis" column indicates that no defects were observed in the tissues under consideration, 
for their particular periods of gestation. 
* Operative specimens. 
Autopsy specimens. 
§ Obtained at parturition. 
[I Venopuncture. 
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Organ  No. of speci-  Pathological diagnosis  mens studied 
Genito-urinary  system: 
Kidney* 
Kidney~ 
Kidney* 
Kidney* 
Prostate* 
Prostate* 
Ovary* 
Ovary* 
Ovary* 
Ovary* 
Uterus* 
Uterus* 
Uterus* 
Endocrine  system: 
Thyroid* 
Thyroid* 
Thyroid* 
Thyroid* 
Adrenal* 
Metastases from carcinoma of the prostate 
Normal 
Hydronephrosis--no  primary pathology 
Renal cell carcinoma 
Benign hyperplasia 
Primary carcinoma 
Normal--postmenopausal 
Benign cystic teratoma 
Benign cysts 
Adenocarcinomat  a--various types 
Normal--postmenopausal 
Fibroids 
Primary carcinoma 
Colloid nodular goitre 
Diffuse co]loid goitre 
Adenoma 
Adenocarcinoma 
Normal--removed therapeutically for car- 
cinoma of the breast 
Reticulo-endothdial  system: 
Spleen~ 
Spleen* 
White blood cells[] 
White blood cells]] 
White blood cells]] 
Mesenchymal  tissues: 
Skeletal muscle~ 
Cardiac muscle* 
Nerve* 
Peritoneum* 
Subcutaneous tissue* 
HeLa cell extract 
Fetal tissues: 
Placenta§ 
Cord Blood§ 
Lung and bronchial tissue* (2-8 
months gestation) 
Kidney:~  (2-8 months gestation) 
Heart~" (2-8 months gestation) 
Spleen:~ (2-8 months gestation) 
Brain:~ (2-8 months gestation) 
Gut* (7-8 months gestation) 
Pancreas*  (7-8 months gesta- 
tion) 
Liver* (7-8 months gestation) 
4 
1 
2 (cases) 
2 (cases) 
2 (cases) 
Normal 
Malignant lymphoma--reticulum  cell type 
Acute myeIogenous  leukemia 
Acute lymphoid leukemia 
Chronic lymphoid leukemia 
12 
6 
10 
10 
10 
10 
4 
3 
3 
3  Normal 
4  Normal 
1  Neurolemmoma 
1  Liposarcoma 
1  Lipoma 
1 
Normal 
Normal 
Normal 
Normal 
Normal 
Normal 
Normal 
Normal 
Normal 
3  Normal 
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the  specific normal  antigenic  component(s),  while  most  colonic carcinomata 
contained negligible quantities.  At first glance,  these results would appear to 
represent  another  example  of  deletion  of  normal  tissue  antigens  during  the 
process of carcinogenesis (ll-18) and to conflict with the findings of the present 
investigation.  However,  this  apparent  contradiction  can  be  reconciled by  a 
somewhat  different  interpretation  of  the  experimental  data.  The  chemical 
nature and distribution of the specific antigens of normal human bowel mucosa 
found  by Nairn  et  al.  showed  marked  similarities  to  the  properties  (1)  and 
distribution of the tumor-specific antigens demonstrated in the present study. 
Thus, it is possible that normal tissue components, apparently deleted during 
the  development of  malignant  tumors  in  the  human  gastrointestinal  tract, 
may actually have been converted into, or replaced by, very similar  compo- 
nents specific to the cancer tissue. 
FIG. 4. Direct Ouchterlony reactions between tl-abs and active tissue extracts, in highest 
or next to highest dilutions, giving positive precipitin-inhibition tests. Center, tl-abs, (A) 
T1, (B) carcinoma of the stomach, (C) carcinoma of the pancreas, (D) carcinoma of the duo- 
denum, (E) carcinoma  of the rectum, (F) fetal liver at 5 months of gestation. 
The tumor-specific antigens demonstrated in the present study could not be 
detected in malignant tumors of the uppermost portion of the digestive system; 
i.e.,  in cancers of the palate, anterior portion of the floor of the mouth, or in a 
malignant  mixed tumor of the parotid gland.  A  possible explanation for this 
finding is  the difference in  the germ layer of origin of the  epithelium of the 
areas  under  consideration.  The  normal  epithelium  of  those  parts  of  the  di- 
gestive  system which  developed the  tumor-specific antigens  upon  malignant 
transformation were derived from embryonic entodermal tissue. This tissue in 
the embryo gives rise to the lining of the continuous fore-, mid-, and hindgut 
tract, extending cephalically to the stomatodaeum and caudally to the procto- 
daeum,  and  becomes the  parenchymal  tissue  of the  pancreas  and  liver.  The 
anterior portion  of  the  floor of  the  mouth,  hard  palate,  and  parotid  gland, 
however,  are  derived  from  the  stomatodaeum  and  are  thus  of  ectodermal 
origin. 
On  the  basis  of  the  foregoing observations,  it is  suggested  that  cancerous 
lesions arising from various sites of the entodermally derived human digestive 
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The findings  of a number of studies, such as those of Makari (2, 3), and of 
Bjorklund et a/. (4), suggested the existence of common tumor-specific  compo- 
nents in different human  cancers.  Commenting  on the observations of these 
investigators, Prehn  (7) stated,  "that none of these findings  has as  yet  been 
shown to be readily reproducible in other laboratories,  and that none  of them 
has, as yet, been accepted by the majority of workers in this field". Kosyakov 
and  Koresteleva (5)  noted that human cancers appeared to fall into certain 
groups with regard to the tumor-specific  antigens they contained, but did not 
indicate the types of tumors assigned  to each particular  group. However, no 
single  tumor-specific  component  was found  to  be common  to  all  cancerous 
tissues. 
Similarly,  the tumor-specific  antigens detected in the present investigation 
were not universally distributed in all human cancer specimens, but were found 
to be present in all tested malignant tumors of the entodermally derived epi- 
thelium of the digestive system. It is believed that  the results of the present 
investigation represent the first demonstration of system-specific  cancer anti- 
gens in humans. 
The Antigens  of the Digestive System  of the Human Fetus.--The localization 
of the demonstrated tumor-specific  antigens to digestive system malignancies 
suggested the possibility of some relationship between them and the embryonic 
development of the human gastrointestinal  tract and its functionally related 
derivatives  (liver  and  pancreas).  For  this  reason,  various  tissues of fetuses 
between 2 and 8 months of gestation were investigated. These studies revealed 
that the antigens which, in the adult, were specifically localized to entodermally 
derived digestive system cancers  were also present in the digestive organs of 
fetuses between 2 and 6 months of gestation. 
The possibility of an  antigenic  similarity  between human  embryonic and 
tumor tissues was suggested by several groups of workers during  the last 35 
years (19-22). The interpretation of the results of these studies is difficult since 
in many cases no consideration was given to the possibility that the supposed 
tumor-specific  antibodies may actually have been directed against iso-antigens, 
species-specific  antigens,  or normal  tissue antigens present in higher  concen- 
trations in embryonic and cancer tissues.  Recently, however, Abelev (15) pre- 
sented convincing  evidence for antigenic reversion in certain mouse hepatomas. 
The results of the present investigation support the possibility of a distinct 
relationship between the system-specific  tumor antigens and certain embryonic 
tissue components of the human  digestive system. These common antigenic 
constituents will henceforth be referred to as "carcinoembryonic" antigens of 
the human  digestive system. The  observations made  in  this  study indicate 
that  the presence  of  carcinoembryonic  constituents  in  the  tissues  in  which 
they were detected is probably dependent upon two factors. The importance 
of the embryonic derivation of the normal  tissue is indicated by the finding 
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gastrointestinal  tract lacked the carcinoembryonic antigens detected in malig- 
nant  lesions  of the entodermally derived parts  of the digestive system. The 
second factor would appear to be the manner of differentiation and specializa- 
tion  which  the  primitive  tissue  undergoes  in  the  process of  forming  adult 
structures.  For example,  neither fetal lung and  bronchial  tissue,  which form 
from  a  bud of entodermally lined foregut,  nor  the corresponding malignant 
lesion  of  bronchogenic  carcinoma  contained  the  carcinoembryonic  antigens 
of the digestive system. It would seem, therefore, that different modes of differ- 
entiation  and  specialization  call  for the presence of different specific cellular 
components during embryonic arid fetal life. 
On the basis of these findings,  it would appear that  during  the embryonic 
and  fetal processes of differentiation,  specialization,  and  organization  which 
take place during the major part of human gestation (23), the entodermal tissue 
of the digestive system contains specific antigenic  components which disappear 
toward the later stages of gestation and normally do not reappear during adult 
life. However, during the anaplastic changes of disorganization  (disorientation) 
and  dedifferentiation  (despecializafion)  associated with the process of malig- 
nant  transformation,  these  components  reappear  as  tumor-specific  antigens 
absent from comparable normal  adult  tissue.  The process of deletion of em- 
bryonic  antigens  from  adult  tissues  has  long  been  recognized  (21,  24-27). 
However, the phenomenon  of the  reappearance  of  the  deleted  or  repressed 
embryonic antigens in cancerous tissue requires further consideration. 
Monod (28) postulated that it is the breakdown of the repressor mechanisms 
determining  the differentiation of the cell which  leads to malignant  transfor- 
mation. The suggested mechanism by which genetic repression and derepression 
may take place in the cell is summarized in Fig. 5 and has resulted from studies 
by Jacob and Monod and their associates  (see references 28-31) with inducible 
and repressible  enzyme systems in bacteria.  Commenting on the possible role 
of repressor mechanisms in carcinogenesis,  Zilber (32) proposed that mutagenic 
carcinogens  such as ionizing radiation could act either by altering the regulator 
genes to derepress inherent genetic information, or by allowing the activation of 
repressed, additional genetic information brought into the cell by carcinogenic 
viruses. Non-mutagenic  carcinogens,  on the other hand,  could inactivate  re- 
pressors by acting as "substrate-inducers".  Observations of impaired repressor 
function  in  neoplastic  disease  have  been made  in  studies  of  the  "minimal 
deviation" hepatomas (see reference  33)  as well as in experiments with other 
cancer systems (34-36). 
On the basis of the foregoing  discussion,  it is possible to formulate a  tenta- 
tive hypothesis to explain the findings of the present investigation. In the very 
early stages of human  embryonic cellular  division,  each primitive cell is en- 
dowed with the totality of inherited genetic information.  This genetic poten- 
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theoretically allow  each  cell to specialize into  any human  cellular form. As 
anatomical orientation is initiated under the influence of certain "organizers" 
(37), distinct organ systems begin to develop. At this stage the pluripotential 
entodermal cells destined to become the epithelial tissue of the digestive system 
prepare for the events which will ultimately lead to the formation of the adult 
structures (gastrointestinal tract, liver, and pancreas).  Systems of "regulator 
gene-repressor-operator" act first to suppress the areas of the nuclear genome 
not required for the differentiation of these cells.  However, the genetic poten- 
tialities necessary to allow the cells to undergo their particular type of special- 
Regulator  Operator  Structural 
6ene  Gene  Genes 
R  0  A  B 
I  I  I  i  Genes 
I  ~  U'U'U'U  Messengers  (m-RNA) 
Repressor  ~ 
( .P  RNA) 
,-~., i-~  ProteJ ns 
Substrata-Inducer 
FIO. 5. Proposed model for the regulation of protein synthesis in somatic cells. Combina- 
tion of repressor  with the operator inhibits the production of m-RNA on the structural genes. 
The introduction of a substrate-inducer, into the cytoplasm, which combines  with repressor 
leads to initiation of m-RNA production on the structural genes and thereby to the synthesis 
of specific  protein molecules  in the cytoplasm. (Adapted from information in Jacob, F., and 
Monad, J., Genetic regulatory mechanisms  in the synthesis of proteins, J. Mol. Biol., 1961, 
3, 318.) 
ization continue to be expressed. Upon adequate differentiation of the digestive 
system epithelium prior to birth,  certain of the  cellular components needed 
during  the course of specialization appear  to be no longer required.  At  this 
stage further repression of genetic information occurs and the production of 
"primitive"  components ceases.  The disappearance  of the  carcinoembryonic 
antigens from fetal gut, liver, and pancreas in the third trimester of gestation 
and their absence from the corresponding normal tissues of the adult is com- 
patible with this hypothetical sequence of events. During  the process of car- 
cinogenesis  in  the  gastrointestinal  tract  and  the  pancreas,  derepression  of 
previously repressed genetic information may occur, leading to the recommence- 
ment of cytoplasmic production of the carcinoembryonic antigens. 
At least two possible mechanisms may be involved in the process of dere- 
pression. Mutagenic carcinogens could derepress genetic information by specifi- 478  SPECIFIC  CARCINOEMBRYONIC  ANTIGENS 
cally  altering  certain  regulator  genes  or operators.  On  the  other  hand,  non- 
mutagenic  carcinogens  could  initiate  an  epigenetic  (38)  sequence  of  dere- 
pression by inactivating certain cytoplasmic repressors. It is also possible that 
the  carcinoembryonic  antigens  demonstrated  in  this  study  reappear  coinci- 
dentally as a  consequence of generalized  derepressive-dedifferentiation  during 
carcinogenesis.  Such an occurrence could result in autonomous cells containing 
these  components  by chance  alone.  However,  since  the  total  genetic  poten- 
tiality of every somatic cell is presumably the same, it seems more than mere 
coincidence  that  the  production  of  the  same  carcinoembryonic  components 
should be activated in all digestive system cancers,  but in none of the malig- 
nant  tumors of any other organ system. 
The system-specificity of the carcinoembryonic antigens  to cancer tissues of 
the digestive organs must also be explained. It is conceivable that carcinogens 
acting upon gastrointestinal and pancreatic tissues have a selective inactivating 
effect on only certain  repressor-operator  circuits.  Alternatively,  the  carcino- 
embryonic components may develop in digestive system cancer cells following 
malignant  transformation  because they  are required  to fulfil some essential, 
but poorly understood,  function in the neoplastic cell.  In the embryonic and 
fetal  digestive  system  entoderm,  the  carcinoembryonic  components  might 
participate directly in the differentiation of the cells.  Although the concept of 
the universal inability of the dedifferentiated cancer cell to redifferentiate has 
been challenged (31, 39, 40), there is as yet no conclusive evidence that rediffer- 
enfiation  of malignant  cells  is  a  general  phenomenon.  Thus,  if  the  carcino- 
embryonic components of the human digestive system were directly responsible 
for cellular differentiation,  they would have little function in a gastrointestinal 
cancer  cell.  Still  another  possibility  is  that  these  constituents  are  active  in 
stimulating rapid cellular proliferation in both fetal and malignant  cells.  How- 
ever, the absence of the carcinoembryonic antigens from fetal digestive organs 
during  the third  trimester,  when rapid  growth is still taking  place,  would be 
difficult to understand  if this latter concept were valid. 
The most satisfying explanation  is that  the carcinoembryonic components, 
in both the fetal and cancer cells, function in maintaining  the viability of these 
cells in  their  incompletely differentiated  state.  Thus,  when  differentiation  is 
completed in the fetal cells to the point where the carcinoembryonic antigens 
disappear,  other mechanisms may become operative in order to maintain  the 
health  and function of the specialized cellular units.  In cancer cells,  however, 
where redifferentiation  to the normal  cell type has not as yet been generally 
shown  to occur,  these  carcinoembryonic  constituents  would have  to  be pro- 
duced continuously in order to maintain  the life of the malignant  cells. 
S~4.R¥ 
A  wide variety of human  adult  and fetal tissues were studied by immuno- 
diffusion techniques in agar gel to determine whether they contained the tumor- PHIL  GOLD  AND  SAMUEL  O.  I~EEDMAN  479 
specific antigen(s) previously found in colonic  cancers.  In the adu/t tissues it 
was demonstrated that identical antigens were present in all tested specimens 
of malignant  tumors  of the  entodermally derived epithelium  of the  gastro- 
intestinal  tract  and  pancreas,  but  were  absent  from  all  other  tested  adult 
tissues.  The  common  antigenic  constituents,  therefore,  represent  system- 
specific cancer antigens of the human digestive system. System-specific cancer 
antigens have not previously been demonstrated in humans. 
Experiments  with fetal  tissues  demonstrated  that  identical  antigens  were 
also present in fetal gut, liver, and pancreas between 2 and 6 months of gesta- 
tion.  These  components  were  named  "carcinoembryonic"  antigens  of  the 
human digestive system. On the basis of the present findings and the recent 
work regarding control of the  expression of genetic potentialities in various 
types of cells,  it was concluded that the carcinoembryonic antigens represent 
cellular constituents which  are repressed during  the course of differentiation 
of the normal digestive system epithelium and reappear in the corresponding 
malignant cells by a process of derepressive-dedifferentiation. 
The authors wish to express their thanks to Miss J. Jonson for invaluable technical assist- 
ance, and to Mr. H. Artinian of the Department of Medical Photography, Montreal General 
Hospital for his aid in the preparation of the figures. 
Addendum.--Since  submission  of this manuscript a  specimen of a  malignant pri- 
mary hepatoma has been obtained for study. Extracts of this tumor were found to 
be active in precipitin-inhibition and direct Ouchterlony reactions in the protein con- 
centration range of 80 to 100 mg/ml. 
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